About
Technology
Issues
FAQ
Links
Official Page
A phase I, open-label, multicenter study to evaluate the pharmacokinetics and safety of oral panobinostat in patients with advanced solid tumors and varying degrees of renal function
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.